**Expenses as a Percentage of Revenue**

**Metric Measured:** Breakdown of expenses (Cost of Revenue, Research & Development, Marketing & Sales, General & Administrative) as a percentage of total revenue across nine quarters (Q1'22 to Q1'24).

**Key Data Points and Values:**

*   **Q1'22:** Cost of Revenue: 22%, R&D: 28%, Marketing & Sales: 12%, G&A: 8% (Total: 70%)
*   **Q2'22:** Cost of Revenue: 18%, R&D: 30%, Marketing & Sales: 12%, G&A: 10% (Total: 70%)
*   **Q3'22:** Cost of Revenue: 21%, R&D: 33%, Marketing & Sales: 14%, G&A: 12% (Total: 80%)
*   **Q4'22:** Cost of Revenue: 26%, R&D: 30%, Marketing & Sales: 14%, G&A: 10% (Total: 80%)
*   **Q1'23:** Cost of Revenue: 21%, R&D: 33%, Marketing & Sales: 11%, G&A: 10% (Total: 75%)
*   **Q2'23:** Cost of Revenue: 19%, R&D: 29%, Marketing & Sales: 10%, G&A: 13% (Total: 71%)
*   **Q3'23:** Cost of Revenue: 18%, R&D: 27%, Marketing & Sales: 8%, G&A: 6% (Total: 59%)
*   **Q4'23:** Cost of Revenue: 19%, R&D: 26%, Marketing & Sales: 8%, G&A: 6% (Total: 59%)
*   **Q1'24:** Cost of Revenue: 18%, R&D: 27%, Marketing & Sales: 7%, G&A: 9% (Total: 61%)

**Significant Trends:**

*   **Total Expenses:** Peaked at 80% of revenue in Q3'22 and Q4'22, then showed a significant decline to a low of 59% in Q3'23 and Q4'23, slightly increasing to 61% in Q1'24. This indicates improved operating leverage or cost control relative to revenue growth.
*   **Research & Development:** Increased from 28% in Q1'22 to a peak of 33% in Q3'22 and Q1'23, then steadily declined to 26-27% by Q3'23-Q1'24.
*   **Marketing & Sales:** Peaked at 14% in Q3'22 and Q4'22, then saw a substantial reduction, dropping to 7% by Q1'24.
*   **Cost of Revenue:** Fluctuated between 18% and 26%, generally remaining in the 18-22% range, with a high of 26% in Q4'22 and a low of 18% in Q2'22, Q3'23, and Q1'24.
*   **General & Administrative:** Varied between 6% and 13%, with a high of 13% in Q2'23, but showing a general downward trend from 2022 levels into 2023-2024.